Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04311086 · ClinicalTrials.gov registry record · NA
SPYRAL DYSTAL Renal Denervation Global Clinical Study
A NA study, sponsored by Medtronic Vascular.
- Completed
- Registry status
- NA
- Development phase
- 128
- Enrollment target
NCT04311086 is a NA study that has completed, run by Medtronic Vascular. The registered enrollment target is 128 participants.
The verdict
NCT04311086, a NA study, has completed, sponsored by Medtronic Vascular.
- COMPLETED
- Registry status
- NA
- Development phase
- 128 participants
- Enrollment target
Study Summary
The objective of this single arm interventional study is to determine if renal denervation performed in the distal main and first order branch renal arteries is as effective in reducing blood pressure as the procedural approach used in the SPYRAL HTN-OFF MED clinical study.
Interventions
- DEVICE Renal Denervation (Symplicity Spyral™)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2020-06-12 |
| Est. Completion | 2022-12-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04311086
The ClinicalTrials.gov registry entry for NCT04311086 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic Vascular, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Renal Denervation (Symplicity Spyral™) is the first listed.
NCT04311086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04311086 about?
NCT04311086 is a clinical study titled "SPYRAL DYSTAL Renal Denervation Global Clinical Study". The objective of this single arm interventional study is to determine if renal denervation performed in the distal main and first order branch renal arteries is as effective in reducing blood pressure as the procedural approach used in the SPYRAL HTN-OFF MED clinical study.
What is the current status of trial NCT04311086?
This trial is currently completed. It is a NA study. The enrollment target is 128 participants. The study started on 2020-06-12. Estimated completion is 2022-12-22.
What interventions are being tested in trial NCT04311086?
The interventions under investigation include: Renal Denervation (Symplicity Spyral™) (DEVICE).
Who is sponsoring clinical trial NCT04311086?
This trial is sponsored by Medtronic Vascular, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.